Regulatory
Peptide status table
The canonical status reference for every compound on this site: human evidence, grade, FDA and compounding status, and sport status.
74 compounds
Sorted by evidence grade. Compounds marked PCAC were reviewed at the July 23-24, 2026 FDA compounding committee meeting. Status describes categories, not legal advice.
| Compound | Grade | Human evidence | FDA / compounding status | Sport status |
|---|---|---|---|---|
| Afamelanotide | A | Strong human evidence | Approved for specific use | Verification needed |
| Desmopressin | A | Strong human evidence | Approved for specific use | Verification needed |
| Oxytocin | A | Strong human evidence | Approved for specific use | Verification needed |
| PT-141 | A | Strong human evidence | Approved for specific use | Verification needed |
| Semaglutide | A | Strong human evidence | Approved for specific use | No additional flag |
| Setmelanotide | A | Strong human evidence | Approved for specific use | Verification needed |
| Tesamorelin | A | Strong human evidence | Approved for specific use | Verification needed |
| Tirzepatide | A | Strong human evidence | Approved for specific use | No additional flag |
| Vasopressin | A | Strong human evidence | Approved for specific use | Verification needed |
| Cagrilintide | B | Moderate human evidence | Investigational / not approved | Verification needed |
| CagriSema | B | Strong human evidence | Investigational / not approved | Verification needed |
| Melanotan-1 | B | Strong human evidence | Varies by product and jurisdiction | Verification needed |
| Retatrutide | B | Moderate human evidence | Investigational / not approved | Verification needed |
| Sermorelin | B | Moderate human evidence | Varies by product and jurisdiction | Verification needed |
| SS-31 / Elamipretide | B | Moderate human evidence | Approved for specific use | Verification needed |
| ARA-290 | C | Limited human evidence | Investigational / not approved | Verification unknown |
| Cerebrolysin | C | Moderate human evidence | Varies by product and jurisdiction | Verification needed |
| CJC-1295 DAC | C | Limited human evidence | Investigational / not approved | Verification needed |
| GHK-Cu | C | Moderate human evidence | Varies by product and jurisdiction | Verification needed |
| GHRP-2 | C | Limited human evidence | Varies by product and jurisdiction | Verification needed |
| Gonadorelin | C | Limited human evidence | Varies by product and jurisdiction | Verification unknown |
| Kisspeptin-10 | C | Limited human evidence | Investigational / not approved | Verification unknown |
| Thymosin alpha-1 | C | Limited human evidence | Varies by product and jurisdiction | Verification needed |
| VIP | C | Limited human evidence | Not FDA-approved for listed uses | Verification needed |
| ACE-031 | D | Limited human evidence | Investigational / not approved | Verification needed |
| AOD-9604 | D | Mostly preclinical | Not FDA-approved for listed uses | Verification needed |
| BPC-157 · PCAC | D | Limited human evidence | Not FDA-approved for listed uses | Verification needed |
| Bronchogen | D | Mostly preclinical | Not FDA-approved for listed uses | Verification needed |
| Cartalax | D | Limited human evidence | Varies by product and jurisdiction | Verification unknown |
| Chonluten | D | Mostly preclinical | Not FDA-approved for listed uses | Verification needed |
| DMSO | D | Limited human evidence | Approved for specific use | Verification unknown |
| DSIP · PCAC | D | Limited human evidence | Investigational / not approved | Verification needed |
| Epitalon · PCAC | D | Mostly preclinical | Investigational / not approved | Verification needed |
| Follistatin-315 | D | Mostly preclinical | Not FDA-approved for listed uses | Verification needed |
| Follistatin-344 | D | Mostly preclinical | Not FDA-approved for listed uses | Verification needed |
| GHK-Cu + KPV Blend · PCAC | D | Mostly preclinical | Investigational / not approved | Verification needed |
| GHRP-6 | D | Limited human evidence | Not FDA-approved for listed uses | Verification needed |
| Glutathione | D | Limited human evidence | Not FDA-approved for listed uses | Verification unknown |
| Hexarelin | D | Limited human evidence | Not FDA-approved for listed uses | Verification needed |
| Ipamorelin | D | Limited human evidence | Investigational / not approved | Verification needed |
| KPV · PCAC | D | Mostly preclinical | Investigational / not approved | Verification needed |
| L-Carnitine | D | Limited human evidence | Approved for specific use | Verification unknown |
| Livagen | D | Mostly preclinical | Not FDA-approved for listed uses | Verification needed |
| LL-37 | D | Limited human evidence | Investigational / not approved | Verification unknown |
| Melanotan-2 | D | Limited human evidence | Not FDA-approved for listed uses | Verification unknown |
| Methylene Blue | D | Limited human evidence | Approved for specific use | Verification unknown |
| MOTS-c · PCAC | D | Limited human evidence | Investigational / not approved | Verification needed |
| NAD+ | D | Limited human evidence | Not FDA-approved for listed uses | Verification unknown |
| Ovagen | D | Mostly preclinical | Not FDA-approved for listed uses | Verification needed |
| Pancragen | D | Mostly preclinical | Not FDA-approved for listed uses | Verification needed |
| Pinealon | D | Mostly preclinical | Investigational / not approved | Verification needed |
| Selank | D | Limited human evidence | Not FDA-approved for listed uses | Verification needed |
| Semax · PCAC | D | Limited human evidence | Varies by product and jurisdiction | Verification needed |
| SHLP2 | D | Mostly preclinical | Not FDA-approved for listed uses | Verification unknown |
| Thymalin | D | Limited human evidence | Varies by product and jurisdiction | Verification needed |
| Thymogen | D | Limited human evidence | Varies by product and jurisdiction | Verification needed |
| Thymosin beta-4 | D | Limited human evidence | Investigational / not approved | Verification needed |
| Vesugen | D | Mostly preclinical | Not FDA-approved for listed uses | Verification needed |
| Adamax · PCAC | E | Evidence unclear | Varies by product and jurisdiction | Verification needed |
| Bacteriostatic water | E | Evidence unclear | Approved for specific use | Verification unknown |
| CJC-1295 no DAC | E | Evidence unclear | Investigational / not approved | Verification unknown |
| CJC-1295 no DAC + Ipamorelin | E | Evidence unclear | Not FDA-approved for listed uses | Verification needed |
| Gut Inflammation Blend | E | Evidence unclear | Not FDA-approved for listed uses | Verification needed |
| HGH Fragment 176-191 | E | Evidence unclear | Not FDA-approved for listed uses | Verification needed |
| IGF-1 DES | E | Evidence unclear | Not FDA-approved for listed uses | Verification needed |
| IGF-1 LR3 | E | Evidence unclear | Not FDA-approved for listed uses | Verification needed |
| KLOW Blend | E | Evidence unclear | Not FDA-approved for listed uses | Verification needed |
| Myostatin propeptide | E | Evidence unclear | Not FDA-approved for listed uses | Verification needed |
| N-Acetyl Selank Amidate | E | Evidence unclear | Not FDA-approved for listed uses | Verification needed |
| N-Acetyl Semax Amidate | E | Evidence unclear | Not FDA-approved for listed uses | Verification needed |
| P21 | E | Evidence unclear | Not FDA-approved for listed uses | Verification needed |
| Sermorelin + Ipamorelin | E | Evidence unclear | Not FDA-approved for listed uses | Verification needed |
| TB-500 · PCAC | E | Evidence unclear | Investigational / not approved | Verification needed |
| Wolverine Blend · PCAC | E | Limited human evidence | Investigational / not approved | Verification needed |